A patented LC-MS diagnostic kit based on protein deamidation kinetics.
Request Scientific Information
Our diagnostic process utilizes advanced LC-MS technology to measure protein deamidation rates, providing precise and actionable insights into biological aging progression.
Traditional chronological age tells us how many years have passed, but it doesn't reveal how fast our bodies are actually aging. Biological aging rate measures the speed of molecular deterioration, providing a more accurate predictor of health outcomes and enabling personalized interventions to slow the aging process.
Argeron Medical develops patented LC-MS diagnostic kits that measure biological aging rate, combined with an optional AI-based clinical decision support platform.
Our technology is designed to answer a fundamentally different question: not how old biology is — but how fast it is changing.
Argeron has developed a patented diagnostic kit that directly measures biological aging rate using LC-MS–based protein analysis.
Explore the biological aging rate diagnostic kit
Biological aging rate is not the same as biological age.
It captures the speed and direction of biological change over time, enabling:
Learn more: What Is Biological Aging Rate?
At the core of the diagnostic kit lies protein deamidation kinetics — a chemically irreversible process that accumulates progressively with time and molecular stress.
This makes it a stable and reliable molecular basis for rate-based aging measurement, rather than static estimation.
Learn more: Protein Deamidation as an Aging Biomarker
Most aging tools estimate biological age. Argeron measures biological aging rate. These are complementary but fundamentally different dimensions of aging biology, with different clinical implications.
Learn more: Argeron BioAgeCheck® vs Epigenetic Clocks
While the diagnostic kit functions independently, users may optionally upload results to Argeron’s AI-based clinical decision support platform.
The AI:
This architecture allows local diagnostics to benefit from globally informed analytical insight, without compromising clinical autonomy.
Learn more: The AI Decision Support Platform
Argeron’s system is intentionally modular:
This design ensures:
Hospitals & Clinical Laboratories
Measuring and monitoring biological aging dynamics
Researchers
Studying aging trajectories and intervention effects
Industry & Platform Partners
Extending LC-MS diagnostics into decision-support workflows
• We measure biological aging rate, not just age
• We do so with a patented LC-MS diagnostic kit
• The kit works without AI
• AI is used only for decision support and reference intelligence
• The result is a clinically grounded, globally scalable aging diagnostics platform
Local measurement.
Global understanding.